Association of Androgen Excess with Glucose Intolerance in Women with Polycystic Ovary Syndrome

Abstract EN

Women with polycystic ovary syndrome (PCOS) show high prevalence of glucose intolerance.

This study aimed to investigate the association of androgen excess with glucose intolerance in PCOS.

A total of 378 women with PCOS participated in the study.

Free androgen index (FAI) was selected as indicator of hyperandrogenism.

Insulin sensitivity was assessed by 1/homeostasis model assessment of insulin resistance (1/HOMA-IR) and Matsuda insulin sensitivity index (ISIM); β-cell function was assessed by disposition index (DI).

We found that women with glucose intolerance had higher FAI levels compared to women with normal glucose tolerance (NGT) (prediabetes 6.2, T2DM 7.9 versus NGT 5.0, resp.; p<0.001).

Furthermore, there was a direct association between FAI levels and frequency of glucose intolerance (OR = 2.480, 95% CI 1.387–4.434), even after adjusting for age, BMI, waist circumference, hypertension, fasting insulin, testosterone, SHBG, and family history of diabetes.

In addition, with FAI increase, glycosylated hemoglobin (HbA1c), plasma glucose concentrations, and serum insulin levels increased, while insulin sensitivity and β-cell function decreased.

Our results suggested that androgen excess indicated by high FAI levels might serve as indicator of glucose intolerance, as it might promote insulin resistance and β-cell dysfunction in women with PCOS.